Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Alnylam Pharmaceuticals Inc.

NAS: ALNY

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Alnylam Pharmaceuticals Inc.

After Hours

ALNY
/zigman2/quotes/205655272/composite

$

170.03

Change

-0.74 -0.43%

Volume

Volume 71,486

Sep 25, 2023, 5:14 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205655272/composite

Previous close

$ 171.55

$ 170.77

Change

-0.78 -0.45%

Day low

Day high

$168.65

$172.31

Open
Open: 170.93

52 week low

52 week high

$168.65

$242.97

Open

Market cap

$21.44B

Average volume

583,369

P/E ratio

N/A

Rev. per Employee

$618,074

EPS

-8.62

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alny

MarketWatch News on ALNY

  1. Incyte Corp. stock outperforms market on strong trading day

    5:16 p.m. Sept. 25, 2023

    - MarketWatch Automation

  2. Incyte Corp. stock underperforms Friday when compared to competitors

    5:16 p.m. Sept. 22, 2023

    - MarketWatch Automation

  3. Incyte Corp. stock underperforms Thursday when compared to competitors

    5:15 p.m. Sept. 21, 2023

    - MarketWatch Automation

  4. Incyte Corp. stock falls Wednesday, still outperforms market

    5:16 p.m. Sept. 20, 2023

    - MarketWatch Automation

  5. Incyte Corp. stock outperforms market on strong trading day

    5:16 p.m. Sept. 19, 2023

    - MarketWatch Automation

  6. Incyte Corp. stock falls Monday, underperforms market

    5:15 p.m. Sept. 18, 2023

    - MarketWatch Automation

  7. Incyte Corp. stock underperforms Friday when compared to competitors

    5:15 p.m. Sept. 15, 2023

    - MarketWatch Automation

  8. Incyte Corp. stock rises Thursday, still underperforms market

    5:15 p.m. Sept. 14, 2023

    - MarketWatch Automation

  10. Incyte Corp. stock falls Wednesday, underperforms market

    5:15 p.m. Sept. 13, 2023

    - MarketWatch Automation

  12. Alnylam Pharmaceuticals’ stock to be halted Wednesday as FDA advisory committee reviews treatment for the Cardiomyopathy of ATTR Amyloidosis

    7:02 a.m. Sept. 13, 2023

    - Ciara Linnane

  13. Incyte Corp. stock outperforms market despite losses on the day

    5:15 p.m. Sept. 12, 2023

    - MarketWatch Automation

  14. Incyte Corp. stock rises Monday, still underperforms market

    5:15 p.m. Sept. 11, 2023

    - MarketWatch Automation

  15. Incyte Corp. stock outperforms competitors on strong trading day

    5:15 p.m. Sept. 8, 2023

    - MarketWatch Automation

  16. Incyte Corp. stock outperforms market on strong trading day

    5:15 p.m. Sept. 7, 2023

    - MarketWatch Automation

  17. Incyte Corp. stock outperforms market despite losses on the day

    5:15 p.m. Sept. 6, 2023

    - MarketWatch Automation

  18. Incyte Corp. stock underperforms Tuesday when compared to competitors

    5:15 p.m. Sept. 5, 2023

    - MarketWatch Automation

  19. Incyte Corp. stock outperforms market on strong trading day

    5:15 p.m. Sept. 1, 2023

    - MarketWatch Automation

  20. Incyte Corp. stock falls Thursday, underperforms market

    5:15 p.m. Aug. 31, 2023

    - MarketWatch Automation

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alny

Other News on ALNY

  1. Health Care Roundup: Market Talk

    6:52 a.m. Sept. 15, 2023

    - The Wall Street Journal Interactive Edition

  2. The Brash Strategy That Made Vivek Ramaswamy a Fortune

    8:01 a.m. Sept. 18, 2023

    - The Wall Street Journal Interactive Edition

  3. For This Venture Capitalist, Research on Aging Is Personal; ‘Bob Has a Big Fear of Death’

    7:03 a.m. Aug. 21, 2023

    - The Wall Street Journal Interactive Edition

  4. 10-Q: ALNYLAM PHARMACEUTICALS, INC.

    8:24 a.m. May 4, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  5. 10-K: ALNYLAM PHARMACEUTICALS, INC.

    9:22 a.m. Feb. 23, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  6. Nuveen Asset Management, LLC Buys 2, Sells 3 in 4th Quarter

    3:00 p.m. Feb. 17, 2023

    - GuruFocus.com

  7. New Biden Law Won’t Kill Drug Cures. It Will Reshape Them.

    3:33 a.m. Jan. 7, 2023

    - The Wall Street Journal Interactive Edition

  10. The Biotech Takeout Menu Gets Pricier

    1:49 p.m. June 1, 2023

    - The Wall Street Journal Interactive Edition

  12. Karani Asset Management LLC Buys 2, Sells 3 in 3rd Quarter

    5:00 p.m. Nov. 23, 2022

    - GuruFocus.com

  14. Nuveen Asset Management, LLC Buys 1, Sells 4 in 3rd Quarter

    5:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  16. The Inflation Reduction Act Is Already Killing Potential Cures

    2:34 a.m. Nov. 4, 2022

    - The Wall Street Journal Interactive Edition

  17. Parametrica Management Ltd Buys 3, Sells 2 in 3rd Quarter

    9:00 a.m. Nov. 3, 2022

    - GuruFocus.com

  18. TOBAM Buys 1, Sells 4 in 3rd Quarter

    9:00 a.m. Nov. 2, 2022

    - GuruFocus.com

/news/pressrelease/company/us/alny

Press Releases on ALNY

  3. Alnylam Issues 2022 Corporate Responsibility Report

    8:18 a.m. May 3, 2023

    - ACCESSWIRE

  4. Alnylam Issues 2022 Corporate Responsibility Report

    8:02 a.m. May 3, 2023

    - 3BL Media

  5. Alnylam Issues 2022 Corporate Responsibility Report

    8:00 a.m. May 3, 2023

    - BusinessWire - BZX

  10. Alnylam Announces Appointment of Peter Kellogg to Board of Directors

    8:00 a.m. March 8, 2023

    - BusinessWire - BZX

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.